{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:20:32Z","timestamp":1791274832480,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T00:00:00Z","timestamp":1278979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10549-010-0988-7","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T11:31:03Z","timestamp":1278934263000},"page":"623-630","source":"Crossref","is-referenced-by-count":42,"title":["Elevated TRF2 in advanced breast cancers with short telomeres"],"prefix":"10.1007","volume":"127","author":[{"given":"Malissa C.","family":"Diehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael O.","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N.","family":"Kimmelshue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen K.","family":"Jackson-Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi C.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne W.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"key":"988_CR1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/350569a0","volume":"350","author":"EH Blackburn","year":"1991","unstructured":"Blackburn EH (1991) Structure and function of telomeres. Nature 350:569\u2013573","journal-title":"Nature"},{"key":"988_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D","volume":"180","author":"SE Holt","year":"1999","unstructured":"Holt SE, Shay JW (1999) Role of telomerase in cellular proliferation and cancer. J Cell Physiol 180:10\u201318","journal-title":"J Cell Physiol"},{"key":"988_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","volume":"33","author":"JK Shay","year":"1997","unstructured":"Shay JK, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787\u2013791","journal-title":"Eur J Cancer"},{"key":"988_CR4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0002-9440(10)63180-X","volume":"164","author":"AK Meeker","year":"2004","unstructured":"Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Marzo AM, Argani P (2004) Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol 164:925\u2013935","journal-title":"Am J Pathol"},{"key":"988_CR5","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-0984-03","volume":"10","author":"AK Meeker","year":"2004","unstructured":"Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10:3317\u20133326","journal-title":"Clin Cancer Res"},{"key":"988_CR6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/labinvest.3700673","volume":"87","author":"Y Deng","year":"2007","unstructured":"Deng Y, Chang S (2007) Role of telomeres and telomerase in genomic instability, senescence, and cancer. Lab Invest 87:1071\u20131076","journal-title":"Lab Invest"},{"key":"988_CR7","doi-asserted-by":"crossref","first-page":"532540","DOI":"10.1038\/sj.onc.1205080","volume":"21","author":"T Lange de","year":"2002","unstructured":"de Lange T (2002) Protection of mammalian telomeres. Oncogene 21:532540","journal-title":"Oncogene"},{"key":"988_CR8","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","volume":"19","author":"T Lange de","year":"2005","unstructured":"de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100\u20132110","journal-title":"Genes Dev"},{"key":"988_CR9","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1126\/science.1069523","volume":"295","author":"J Karlseder","year":"2002","unstructured":"Karlseder J, Smogorsewska A, de Lange T (2002) Senescence induced by altered telomere state, not telomere loss. Science 295:2446\u20132449","journal-title":"Science"},{"key":"988_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3835(02)00706-1","volume":"194","author":"J Karlseder","year":"2003","unstructured":"Karlseder J (2003) Telomere repeat binding factors: keeping the ends in check. Cancer Lett 194:189\u2013197","journal-title":"Cancer Lett"},{"key":"988_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.pap.0000138145.19258.64","volume":"11","author":"A Baykal","year":"2004","unstructured":"Baykal A, Rosen D, Zhou C, Liu J, Sahin AA (2004) Telomerase in breast cancer. Adv Anat Pathol 11:262\u2013268","journal-title":"Adv Anat Pathol"},{"key":"988_CR12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.283.5406.1321","volume":"283","author":"J Karlseder","year":"1999","unstructured":"Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321\u20131325","journal-title":"Science"},{"key":"988_CR13","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/sj.onc.1208482","volume":"24","author":"T Nijjar","year":"2005","unstructured":"Nijjar T, Bassett E, Garbe J, Takenaka Y, Stampfer MR, Gilley D, Yaswen P (2005) Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene 24:3369\u20133376","journal-title":"Oncogene"},{"key":"988_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1101\/gad.406207","volume":"21","author":"R Blanco","year":"2007","unstructured":"Blanco R, Munoz P, Flores JM, Klatt P, Blasco MA (2007) Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev 21:206\u2013220","journal-title":"Genes Dev"},{"key":"988_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-007-9622-8","volume":"109","author":"M Salhab","year":"2008","unstructured":"Salhab M, Jiang WG, Newbold RF, Mokbel K (2008) The expression of gene transcripts of telomere-associated proteins in human breast cancer: correlation with clinic-pathological parameters and clinical outcome. Breast Cancer Res Treat 109:35\u201346","journal-title":"Breast Cancer Res Treat"},{"key":"988_CR16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4161\/cbt.7.6.5861","volume":"6","author":"X Di","year":"2008","unstructured":"Di X, Bright AT, Gaskins, Robert J, Holt S, Gewirtz DA, Elmore LW (2008) A chemotherapy-associated senescence bystander effect in breast cancer cells. Cancer Biol Ther 6:864\u2013872","journal-title":"Cancer Biol Ther"},{"key":"988_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.15.1.425","volume":"15","author":"JW Shay","year":"1995","unstructured":"Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS (1995) Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 15:425\u2013432","journal-title":"Mol Cell Biol"},{"key":"988_CR18","first-page":"6075","volume":"18","author":"HD Soule","year":"1990","unstructured":"Soule HD, Maloney TM, Wolams SR, Peterson WD et al (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 18:6075\u20136086","journal-title":"Cancer Res"},{"key":"988_CR19","doi-asserted-by":"crossref","first-page":"35509","DOI":"10.1074\/jbc.M205477200","volume":"277","author":"LW Elmore","year":"2002","unstructured":"Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, Gewirtz DA, Holt SE (2002) Adriamycin induces telomere length-dependent senescence in breast tumor cells. J Biol Chem 277:35509\u201335515","journal-title":"J Biol Chem"},{"key":"988_CR20","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.77.3.1992-2002.2003","volume":"77","author":"Z Deng","year":"2003","unstructured":"Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM (2003) Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol 77:1992\u20132001","journal-title":"J Virol"},{"key":"988_CR21","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1128\/MCB.00944-08","volume":"13","author":"N Huda","year":"2009","unstructured":"Huda N, Tanaka H, Mendonca MS, Gilley D (2009) DNA damage-induced phosphorylation of TRF2 is required for the fast pathways of DNA double-strand break repair. Mol Cell Biol 13:3597\u20133604","journal-title":"Mol Cell Biol"},{"key":"988_CR22","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.4161\/cbt.8.20.9639","volume":"8","author":"MC Diehl","year":"2009","unstructured":"Diehl MC, Idowu MO, Kimmelshue K, York TP, Elmore LW, Holt SE (2009) Elevated expression of nuclear Hsp90 in invasive breast tumors. Cancer Biol Ther 8:1952\u20131961","journal-title":"Cancer Biol Ther"},{"key":"988_CR23","first-page":"759","volume":"58","author":"RB Jenkins","year":"1998","unstructured":"Jenkins RB, Qian J, Lee HK, Huang H et al (1998) A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 58:759\u2013766","journal-title":"Cancer Res"},{"key":"988_CR24","unstructured":"R Development Core Team (2009) R: a language and environment for the statistical computing. R. Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL: http:\/\/www.R-project.org"},{"key":"988_CR25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1074\/jbc.M109.038026","volume":"285","author":"KK Takai","year":"2010","unstructured":"Takai KK, Hooper S, Blackwood S, Gandhi R, de Lange T (2010) In vivo stoichiometry of shelterin components. J Biol Chem 285:1457\u20131467","journal-title":"J Biol Chem"},{"key":"988_CR26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1582-4934.2005.tb00395.x","volume":"9","author":"K-W Lin","year":"2005","unstructured":"Lin K-W, Yan J (2005) The telomere length dynamic and methods of its assessment. J Cell Mol Med 9:977\u2013989","journal-title":"J Cell Mol Med"},{"key":"988_CR27","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/1097-0142(19940615)73:12<2978::AID-CNCR2820731215>3.0.CO;2-5","volume":"73","author":"E Odagiri","year":"1994","unstructured":"Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H (1994) Reduction of telomeric length and c-erbB2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 73:2978\u20132984","journal-title":"Cancer"},{"key":"988_CR28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/gcc.20608","volume":"47","author":"A Poonepalli","year":"2008","unstructured":"Poonepalli A, Banerjee B, Ramnarayanan K, Palanisamy N, Putti TC, Hande MP (2008) Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer. Genes Chromosomes Cancer 47:1098\u20131109","journal-title":"Genes Chromosomes Cancer"},{"key":"988_CR29","unstructured":"Raynaud CM, Hernandez J, Llorca FP, Nuciforon P et al (2009) DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol Oct 30. [Epub ahead of print]"},{"key":"988_CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ng1506","volume":"37","author":"PS Bradshaw","year":"2005","unstructured":"Bradshaw PS, Stavropoulous DJ, Meyn MS (2005) Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat Genet 37:193\u2013197","journal-title":"Nat Genet"},{"key":"988_CR31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1245\/s10434-006-9147-0","volume":"14","author":"PF Escobar","year":"2007","unstructured":"Escobar PF, Patrick RJ, Rybicki LA, Weng DE, Crowe JP (2007) The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups. Ann Surg Oncol 14:143\u2013147","journal-title":"Ann Surg Oncol"},{"key":"988_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-006-9204-1","volume":"99","author":"CA Fordyce","year":"2006","unstructured":"Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL et al (2006) Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat 99:193\u2013202","journal-title":"Cancer Res Treat"},{"key":"988_CR33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3835(96)04304-2","volume":"106","author":"P Rogalla","year":"1996","unstructured":"Rogalla P, Rohen C, Bonk U, Bullerdiek J (1996) Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers. Cancer Lett 106:155\u2013161","journal-title":"Cancer Lett"},{"key":"988_CR34","doi-asserted-by":"crossref","unstructured":"Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW (1996) Telomerase activity in human breast tumors. 88:116\u2013122","DOI":"10.1093\/jnci\/88.2.116"},{"key":"988_CR35","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4161\/cbt.5.8.2877","volume":"5","author":"H Ning","year":"2006","unstructured":"Ning H, Li TT, Zhao L, Li T, Li J, Liu J, Liu Z, Fan D (2006) TRF2 promotes multidrug resistance in gastric cancer cells. Cancer Biol Ther 5:950\u2013956","journal-title":"Cancer Biol Ther"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0988-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0988-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0988-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:14:43Z","timestamp":1559261683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0988-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0988-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,13]]}}}